Chemoinformaics analysis of 4BETA-HYDROXYWITHANOLIDE-E
| Molecular Weight | 502.604 | nRot | 2 |
| Heavy Atom Molecular Weight | 464.3 | nRig | 31 |
| Exact Molecular Weight | 502.257 | nRing | 6 |
| Solubility: LogS | -3.66 | nHRing | 2 |
| Solubility: LogP | 1.661 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 78.5141 |
| nHD | 4 | BPOL | 43.3299 |
| QED | 0.386 |
| Synth | 5.995 |
| Natural Product Likeliness | 3 |
| NR-PPAR-gamma | 0.169 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.783 |
| Pgp-sub | 0.157 |
| HIA | 0.123 |
| CACO-2 | -5.167 |
| MDCK | 0.0000204 |
| BBB | 1 |
| PPB | 0.631333 |
| VDSS | 0.762 |
| FU | 0.234885 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.928 |
| CYP2c19-inh | 0.058 |
| CYP2c19-sub | 0.891 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.076 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.139 |
| CYP3a4-inh | 0.475 |
| CYP3a4-sub | 0.938 |
| CL | 7.775 |
| T12 | 0.187 |
| hERG | 0.03 |
| Ames | 0.079 |
| ROA | 0.976 |
| SkinSen | 0.027 |
| Carcinogencity | 0.694 |
| EI | 0.008 |
| Respiratory | 0.706 |
| NR-Aromatase | 0.862 |
| Antiviral | Yes |
| Prediction | 0.802145 |